Pazopanib, Another Drug in the Arsenal of Weapons Against Renal Cell Cancer – ESMO 2012
Pazopanib, another drug in the arsenal of weapons against renal cell cancer – ESMO 2012 – Cora Sternberg describes an interesting phase III study confirming the positive results for a new drug in RCC treatment. This study was presented during ESMO 2012, the Congress of the European Society for Medical Oncology. Read all the news about the latest in cancer and oncology from the Congress here www.esmo.org The opinion expressed in this interview reflects that of the interviewee and does not necessarily express the official ESMO point of view.
We Need a Conceptual Breakthrough in the War on Drugs
Filed under: drug treatment news 2012
Submit this story. digg reddit stumble. Among the misconceptions fostered by AA and the disease theory of addiction is the idea of "hitting bottom" — that there is some objective state beneath which no human being will go. … Well, there were these …
Read more on Huffington Post
Ultrafiltration Fails To Show Benefit In Acute Heart Failure
Filed under: drug treatment news 2012
UF was inferior to standard pharmacologic therapy as assessed by the primary endpoint of the trial, which was the bivariate change in serum cretinine and weight measured at 96 hours. Weight loss was similar between the groups (5.5 kg in the drug …
Read more on Forbes